Form 8-K - Current report:
SEC Accession No. 0001193125-23-296047
Filing Date
2023-12-15
Accepted
2023-12-15 08:36:14
Documents
56
Period of Report
2023-12-15
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d576717d8k.htm   iXBRL 8-K 25036
2 EX-99.1 d576717dex991.htm EX-99.1 47785
6 GRAPHIC g576717ex99_1s10g1.jpg GRAPHIC 88806
7 GRAPHIC g576717ex99_1s11g1.jpg GRAPHIC 77272
8 GRAPHIC g576717ex99_1s12g1.jpg GRAPHIC 56622
9 GRAPHIC g576717ex99_1s13g1.jpg GRAPHIC 70412
10 GRAPHIC g576717ex99_1s14g1.jpg GRAPHIC 29669
11 GRAPHIC g576717ex99_1s15g1.jpg GRAPHIC 77808
12 GRAPHIC g576717ex99_1s16g1.jpg GRAPHIC 82479
13 GRAPHIC g576717ex99_1s17g1.jpg GRAPHIC 35622
14 GRAPHIC g576717ex99_1s18g1.jpg GRAPHIC 85195
15 GRAPHIC g576717ex99_1s19g1.jpg GRAPHIC 85258
16 GRAPHIC g576717ex99_1s1g1.jpg GRAPHIC 43421
17 GRAPHIC g576717ex99_1s20g1.jpg GRAPHIC 89290
18 GRAPHIC g576717ex99_1s21g1.jpg GRAPHIC 59604
19 GRAPHIC g576717ex99_1s22g1.jpg GRAPHIC 72241
20 GRAPHIC g576717ex99_1s23g1.jpg GRAPHIC 84715
21 GRAPHIC g576717ex99_1s24g1.jpg GRAPHIC 83553
22 GRAPHIC g576717ex99_1s25g1.jpg GRAPHIC 73339
23 GRAPHIC g576717ex99_1s26g1.jpg GRAPHIC 82559
24 GRAPHIC g576717ex99_1s27g1.jpg GRAPHIC 80364
25 GRAPHIC g576717ex99_1s28g1.jpg GRAPHIC 76790
26 GRAPHIC g576717ex99_1s29g1.jpg GRAPHIC 32786
27 GRAPHIC g576717ex99_1s2g1.jpg GRAPHIC 140879
28 GRAPHIC g576717ex99_1s30g1.jpg GRAPHIC 85093
29 GRAPHIC g576717ex99_1s31g1.jpg GRAPHIC 62747
30 GRAPHIC g576717ex99_1s32g1.jpg GRAPHIC 75911
31 GRAPHIC g576717ex99_1s33g1.jpg GRAPHIC 89470
32 GRAPHIC g576717ex99_1s34g1.jpg GRAPHIC 77394
33 GRAPHIC g576717ex99_1s35g1.jpg GRAPHIC 78402
34 GRAPHIC g576717ex99_1s36g1.jpg GRAPHIC 36346
35 GRAPHIC g576717ex99_1s37g1.jpg GRAPHIC 84824
36 GRAPHIC g576717ex99_1s38g1.jpg GRAPHIC 80085
37 GRAPHIC g576717ex99_1s39g1.jpg GRAPHIC 59986
38 GRAPHIC g576717ex99_1s3g1.jpg GRAPHIC 100672
39 GRAPHIC g576717ex99_1s40g1.jpg GRAPHIC 30601
40 GRAPHIC g576717ex99_1s41g1.jpg GRAPHIC 79965
41 GRAPHIC g576717ex99_1s42g1.jpg GRAPHIC 52005
42 GRAPHIC g576717ex99_1s43g1.jpg GRAPHIC 28783
43 GRAPHIC g576717ex99_1s4g1.jpg GRAPHIC 67390
44 GRAPHIC g576717ex99_1s5g1.jpg GRAPHIC 86208
45 GRAPHIC g576717ex99_1s6g1.jpg GRAPHIC 80197
46 GRAPHIC g576717ex99_1s7g1.jpg GRAPHIC 106269
47 GRAPHIC g576717ex99_1s8g1.jpg GRAPHIC 30493
48 GRAPHIC g576717ex99_1s9g1.jpg GRAPHIC 90729
  Complete submission text file 0001193125-23-296047.txt   4476589

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA wve-20231215.xsd EX-101.SCH 2875
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE wve-20231215_lab.xml EX-101.LAB 17927
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wve-20231215_pre.xml EX-101.PRE 11255
50 EXTRACTED XBRL INSTANCE DOCUMENT d576717d8k_htm.xml XML 3326
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

EIN.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37627 | Film No.: 231488895
SIC: 2834 Pharmaceutical Preparations